Impact of a prevention bundle on Clostridium difficile infection rates in a hospital in the Southeastern United States

被引：10
|
作者：
Davis, Bionca M. [1 ]
Yin, Jingjing [2 ]
Blomberg, Doug [3 ]
Fung, Isaac Chun-Hai [1 ]
机构：
[1] Georgia Southern Univ, Dept Epidemiol, Jiann Ping Hsu Coll Publ Hlth, Statesboro, GA 30460 USA
[2] Georgia Southern Univ, Dept Biostat, Jiann Ping Hsu Coll Publ Hlth, Statesboro, GA 30460 USA
[3] St Marys Hosp & Hlth Care Syst, Infect Control, Athens, GA USA
来源：
AMERICAN JOURNAL OF INFECTION CONTROL | 2016年 / 44卷 / 12期
关键词：
Clostridium difficile; nosocomial infections; prevention program; infection control;
D O I：
10.1016/j.ajic.2016.05.014
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
We sought to assess the impact of a multicomponent prevention program on hospital-acquired Clostridium difficile infections in a hospital in the Southeastern United States. We collected retrospective data of 140 patients from years 2009-2014 and applied the Poisson regression model for analysis. We did not find any significant associations of increased risk of Clostridium difficile infections for the preintervention group. Further studies are needed to test multifaceted bundles in hospitals with high infection rates. (C) 2016 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码：1729 / 1731
页数：3
相关论文
共 50 条
  • [41] Prevention of Infection due to Clostridium (Clostridioides) difficile
    Krishna, Amar
    Chopra, Teena
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2021, 35 (04) : 995 - 1011
  • [42] Breakthroughs in the treatment and prevention of Clostridium difficile infection
    Kociolek, Larry K.
    Gerding, Dale N.
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2016, 13 (03) : 150 - 160
  • [43] Breakthroughs in the treatment and prevention of Clostridium difficile infection
    Larry K. Kociolek
    Dale N. Gerding
    Nature Reviews Gastroenterology & Hepatology, 2016, 13 : 150 - 160
  • [44] Impact of malignancy on Clostridium difficile infection
    M. S. Chung
    J. Kim
    J. O. Kang
    H. Pai
    European Journal of Clinical Microbiology & Infectious Diseases, 2016, 35 : 1771 - 1776
  • [45] Impact of malignancy on Clostridium difficile infection
    Chung, M. S.
    Kim, J.
    Kang, J. O.
    Pai, H.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2016, 35 (11) : 1771 - 1776
  • [46] Prevention of Clostridium difficile infection in rural hospitals
    Haun, Nicholas
    Hofer, Adam
    Greene, M. Todd
    Borlaug, Gwen
    Pritchett, Jenny
    Scallon, Tina
    Safdar, Nasia
    AMERICAN JOURNAL OF INFECTION CONTROL, 2014, 42 (03) : 311 - 315
  • [47] Detection, Treatment, and Prevention of Clostridium difficile Infection
    McCollum, David L.
    Rodriguez, J. Martin
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (06) : 581 - 592
  • [48] Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection
    Wilcox, M. H.
    Gerding, D. N.
    Poxton, I. R.
    Kelly, C.
    Nathan, R.
    Birch, T.
    Cornely, O. A.
    Rahav, G.
    Bouza, E.
    Lee, C.
    Jenkin, G.
    Jensen, W.
    Kim, Y. -S.
    Yoshida, J.
    Gabryelski, L.
    Pedley, A.
    Eves, K.
    Tipping, R.
    Guris, D.
    Kartsonis, N.
    Dorr, M. -B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (04): : 305 - 317
  • [49] Control of Clostridium difficile infection in the hospital setting
    Wiuff, Camilla
    Murdoch, Heather
    Coia, John E.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2014, 12 (04) : 457 - 469
  • [50] Bed Occupancy Rates and Hospital-Acquired Clostridium difficile Infection: A Cohort Study
    Ahyow, Lauren C.
    Lambert, Paul C.
    Jenkins, David R.
    Neal, Keith R.
    Tobin, Martin
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2013, 34 (10): : 1062 - 1069
12345